|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Net sales | ||
| Cost of goods sold | ||
| Gross profit | ||
| Selling, general and administrative expenses | ||
| Goodwill impairment | ||
| Impairment of other assets | ||
| Impairment and restructuring costs | ||
| Transaction and integration-related expenses associated with the Combination | ||
| Operating profit | ||
| Interest expense, net | ||
| Pension and other postretirement non-service income (expense), net | ||
| Other expense, net | ||
| Income before income taxes | ||
| Income tax expense | ||
| Net income | ||
| Net income attributable to noncontrolling interests | ||
| Net income attributable to common shareholders | ||
| Basic earnings per share attributable to common shareholders (in USD per share) | ||
| Diluted earnings per share attributable to common shareholders (in USD per share) |
Loading...
